Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2012
Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer
L H Jensen, J Lindebjerg, J Ploen, et al.
Journal of Evolutionary Biology
|
March 6, 2004
Consequences of inter-population crosses on developmental stability and canalization of floral traits in Dalechampia scandens (Euphorbiaceae)
C Pélabon, M L Carlson, T F Hansen, et al.
Scientific Reports
|
January 16, 2020
Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
A H Zedan, P J S Osther, J Assenholt, et al.
British Journal of Cancer
|
January 14, 2015
Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer
T F Hansen, A L Carlsen, N H H Heegaard, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 14, 2018
Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma
C B Thomsen, T F Hansen, R F Andersen, et al.
Journal of Evolutionary Biology
|
March 13, 2012
Artificial selection on allometry: change in elevation but not slope
C K Egset, T F Hansen, A LE Rouzic, et al.
British Journal of Cancer
|
August 8, 2013
MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial
T F Hansen, R dP Christensen, R F Andersen, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
July 3, 2010
The relationship between serum vascular endothelial growth factor A and microsatellite instability in colorectal cancer
T F Hansen, L H Jensen, K-L G Spindler, et al.
The Pharmacogenomics Journal
|
February 4, 2010
The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer
T F Hansen, K-L Garm Spindler, R F Andersen, et al.
Scientific Reports
|
October 10, 2023
Natural killer cell activity in metastatic castration resistant prostate cancer patients treated with enzalutamide
A H Zedan, L Nederby, L M Volmer, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2012
Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer
L H Jensen, J Lindebjerg, J Ploen, et al.
Journal of Evolutionary Biology
|
March 6, 2004
Consequences of inter-population crosses on developmental stability and canalization of floral traits in Dalechampia scandens (Euphorbiaceae)
C Pélabon, M L Carlson, T F Hansen, et al.
Scientific Reports
|
January 16, 2020
Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
A H Zedan, P J S Osther, J Assenholt, et al.
British Journal of Cancer
|
January 14, 2015
Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer
T F Hansen, A L Carlsen, N H H Heegaard, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 14, 2018
Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma
C B Thomsen, T F Hansen, R F Andersen, et al.
Journal of Evolutionary Biology
|
March 13, 2012
Artificial selection on allometry: change in elevation but not slope
C K Egset, T F Hansen, A LE Rouzic, et al.
British Journal of Cancer
|
August 8, 2013
MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial
T F Hansen, R dP Christensen, R F Andersen, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
July 3, 2010
The relationship between serum vascular endothelial growth factor A and microsatellite instability in colorectal cancer
T F Hansen, L H Jensen, K-L G Spindler, et al.
The Pharmacogenomics Journal
|
February 4, 2010
The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer
T F Hansen, K-L Garm Spindler, R F Andersen, et al.
Scientific Reports
|
October 10, 2023
Natural killer cell activity in metastatic castration resistant prostate cancer patients treated with enzalutamide
A H Zedan, L Nederby, L M Volmer, et al.
Page
of 3